Structural Heart

This structural heart channel includings content related to heart valve repair and replacement, left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and occlusion of ASDs, VSDs and PFOs.

BioTrace Medical's Tempo Lead Obtains CE Mark for Temporary Intracardiac Pacing
News | Leads Implantable Devices | May 13, 2019

May 13, 2019 — BioTrace Medical Inc. announced the company’s Tempo Lead has obtained CE Mark certification in Europe...

EuroPCR 2019 Hot Line Late Breaking trial presentations.
Feature | EuroPCR | May 10, 2019

May 10, 2019 — Here is the list of the late-breaking hot line studies being presented at the 2019 EuroPCR...

Patient Lillian Keavey speaks with Henry Ford cardiologists William O'Neill and Dee Dee Wang about her case. She was the 1,000th patients at Henry Ford to have their procedure guided by 3-D print.

Patient Lillian Keavey speaks with Henry Ford cardiologists William O'Neill and Dee Dee Wang about her case. She was the 1,000th patients at Henry Ford to have their procedure guided by 3-D print.

News | Medical 3-D Printing | April 26, 2019

April 26, 2019 — A 72-year-old woman from northern Michigan became...

Figure 1: A computed tomography angiography (CTA) study performed for transcatheter aortic valve replacement planning.  Interventional imagers created and interpret these images as part of the heart team.

Figure 1: A computed tomography angiography (CTA) study performed for transcatheter aortic valve replacement planning. The aortic valve is trileaflet with significant calcification (A). Annular measurements are performed to determine valve sizing (B). Coronary artery height is measured to predict the risk of coronary artery obstruction (C).  

Feature | Structural Heart | April 24, 2019 | Nadeen N. Faza, M.D., Dee Dee Wang, M.D., Joao Cavalcante, M.D., Andrew D. Choi, M.D., Jeffrey B. Geske, M.D., and Stephen H. Little, M.D.
Recent months have signaled a new and exciting era in the dynamic world of...
Boston Scientific Receives FDA Approval for Lotus Edge Aortic Valve System
Feature | Heart Valve Technology | April 23, 2019 | Dave Fornell, Editor

April 23, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Boston Scientific Lotus Edge...

New Consensus Document Explores Optimized Care for Valvular Heart Disease Patients
News | Heart Valve Technology | April 22, 2019

April 22, 2019 — Five cardiovascular professional societies released a new consensus document on optimizing care for...

FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019

April 18, 2019 — The U.S. Food and Drug Administration published a draft guidance titled, “...

Overlay Init